Edition:
United States

Agilent Technologies Inc (A)

A on New York Consolidated

59.77USD
23 Jun 2017
Change (% chg)

$-0.84 (-1.39%)
Prev Close
$60.61
Open
$60.59
Day's High
$60.59
Day's Low
$59.50
Volume
2,879,785
Avg. Vol
2,012,863
52-wk High
$61.15
52-wk Low
$41.98

Latest Key Developments (Source: Significant Developments)

Enzo Biochem Inc reaches $9 million patent infringement settlement with Agilent Technologies Inc
Wednesday, 6 Jan 2016 08:30am EST 

Enzo Biochem Inc:Has reached and finalized a settlement with Agilent Technologies Inc payment of $9 million to Enzo in an infringement action brought by Enzo regarding its U.S. Patent No. 7,064,197.Says resolved suit involves one of 11 infringement cases brought in delaware federal district court, eight of which remain pending.  Full Article

Protea Biosciences Group, Inc announces Biopharm Industry Collaboration
Tuesday, 8 Dec 2015 08:00am EST 

Protea Biosciences Group, Inc:Says it is collaborating with Agilent Technologies, Inc to address customer challenges within existing Biopharma bioanalytical workflows in order to meet the emerging needs of the growing biopharmaceutical industry.Memorandum of Understanding (MOU), Protea, using Agilent instrumentation combined with its technology, will develop workflows that focus on developing new methods for the field of metabolomics.  Full Article

Agilent Technologies Inc announces cash dividend
Thursday, 19 Nov 2015 04:05pm EST 

Agilent Technologies Inc:Says increased the company's quarterly dividend to 11.5 cents per share of common stock.Paid on Jan. 27, 2016, to all shareholders of record as of the close of business on Jan. 5, 2016.  Full Article

Agilent Technologies Inc gives Q1, FY 2016 guidance below analysts' estimates
Monday, 16 Nov 2015 04:05pm EST 

Agilent Technologies Inc:Sees Q1 2016 revenue guidance of $1.0 billion to $1.02 billion, and non-GAAP earnings guidance of $0.42 to $0.44 per share.Sees FY 2016 revenue guidance of $4.15 billion to $4.17 billion, and non-GAAP earnings guidance of $1.85 to $1.91 per share.Q1 2016 revenue of $1.05 billion and EPS of $0.46 - Thomson Reuters I/B/E/S.FY 2016 revenue of $4.20 billion and EPS of $1.97 - Thomson Reuters I/B/E/S.  Full Article

Dako, an Agilent Technologies Inc Company, Announces FDA Approval of New Test for Lung Cancer Patients
Monday, 12 Oct 2015 02:06am EDT 

Agilent Technologies Inc:Dako, says that the U.S. Food and Drug Administration has approved a new test that can identify PD-L1 expression levels on the surface of non-small cell lung cancer tumor cells and provide information on the survival benefit with OPDIVO (nivolumab) for patients with non-squamous NSCLC.  Full Article

Agilent Technologies Inc announces cash dividend of 10 cents per share
Wednesday, 16 Sep 2015 04:05pm EDT 

Agilent Technologies Inc:Says quarterly dividend of 10 cents per share of common stock will be paid on Oct. 21, to all shareholders of record as of close of business on Sept. 29.  Full Article

Agilent Technologies, Inc acquire Seahorse Bioscience
Wednesday, 9 Sep 2015 04:05pm EDT 

Agilent Technologies, Inc:To acquire seahorse bioscience, industry leader in tools for measuring cell metabolism.Deal for $235 million.Says transaction is expected to be accretive in FY 2016 to Agilent and will be debt financed.  Full Article

Agilent Technologies Inc collaborating with Weill Cornell Medical College to Advance Research in ALS
Wednesday, 26 Aug 2015 11:00am EDT 

Agilent Technologies Inc:Says is collaborating with Steven Gross, a faculty member in the Department of Pharmacology at Weill Cornell Medical College, in New York, N.Y., to advance research in amyotrophic lateral sclerosis, also known as Lou Gehrig's disease.Agilent will provide the latest mass spectrometry technology to support his research.  Full Article

Agilent Technologies Inc lowers FY 2015 revenue guidance; narrows FY 2015 EPS guidance; gives Q4 2015 guidance; revenue guidance below analysts' estimates
Monday, 17 Aug 2015 04:05pm EDT 

Agilent Technologies Inc:Expects Q4 2015 revenue in the range of $1.03 billion to $1.05 billion.Expects Q4 2015 non-GAAP earnings to be in the range of $0.45 to $0.49 per share.Expects FY 2015 revenue of $4.03 billion to $4.05 billion.Expects FY 2015 non-GAAP earnings of $1.68 to $1.72 per share.Q4 2015 revenue of $1.06 billion and EPS of $0.49 - Thomson Reuters I/B/E/S.FY 2015 revenue of $4.06 billion and EPS of $1.70 - Thomson Reuters I/B/E/S.  Full Article

More From Around the Web

BRIEF-Agilent Technologies, Agendia to develop RNA-SEQ kit version of Agendia's mammaprint, blueprint tests

* Co, Agendia Inc to expand relationship to develop RNA-SEQ kit version of Agendia's currently marketed mammaprint, blueprint tests